The Partnership Tree Logo
 
 
 
 
 
 
Sprout Pharmaceuticals, Inc. Logo  
 
 
Services Profile
 
If you'd like to claim this company profile for Sprout Pharmaceuticals, Inc., please Contact Us.
 

Sprout Pharmaceuticals, Inc. News

The latest news, announcements and press releases from Sprout Pharmaceuticals, Inc..

 
 
29
March
2016
29th March 2016
 

Sprout shareholders say company has set price too high, not marketing pill properly

Valeant/Sprout fails to satisfy investors in ‘female viagra’
 
Read the full story »
 
 
10
December
2015
10th December 2015
 

Sprout CEO Whitehead departs Valeant

In August, female libido drug maker Sprout agreed to a $1 billion buyout from Valeant ($VRX) that would make it a division of the Canadian pharma run by its current CEO, Cindy Whitehead. Now, though--less than four months later--Whitehead is on her way out.
 
Read the full story »
 
 
20
August
2015
20th August 2015
 

Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals

Laval, Quebec and Raleigh, NC — August 20, 2015 — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Sprout Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a wholly-owned subsidiary of Valeant will acquire Sprout, on a debt-free basis, for approximately $1 billion in cash, plus a share of future profits based upon the achievement of certain milestones.
 
Read the full story »
 
 
18
August
2015
18th August 2015
 

Sprout Pharmaceuticals Receives FDA Approval of ADDYI™ (Flibanserin 100 MG)

Raleigh, N.C. – August 18, 2015 – Sprout Pharmaceuticals, Inc. (Sprout) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of Addyi™ (flibanserin 100 mg) (pronounced add-ee), a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Addyi is the first and only FDA-approved treatment for this condition, the most common form of female sexual dysfunction, affecting up to 1 in 10 women in the United States.1
 
Read the full story »
 
 
 

Claim This Profile

This is the News section of the company profile page for Sprout Pharmaceuticals, Inc. on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

 
 
Sprout Pharmaceuticals, Inc. company details, activities, contacts and reviews.
 
Sprout Pharmaceuticals, Inc. latest news, announcements and press releases.
 
Sprout Pharmaceuticals, Inc. legal and financial information.
 
Sprout Pharmaceuticals, Inc. documents, images and videos.
 
Sprout Pharmaceuticals, Inc. global factories, offices and locations.
 
Sprout Pharmaceuticals, Inc. blogs, articles and journal posts.
 
Sprout Pharmaceuticals, Inc. partnership and licensing opportunities.
 
 
 
 
 
 
 

About Us

The Partnership Tree established in 2003 (initially a pharmaceutical company directory) supporting companies in the finding, qualification and management of quality vendors and technical partners in the pharmaceutical. biotech and medical devices industry.

The Partnership Tree supports the finding and egagement with technical and commercial partners. It also incorporates software applications that support successful partner engagement and management. These include the building and deployment of questionnaires and assessments for vendor qualification, document excahnge, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at www.thepartnersplatform.com 

 
 
 

Get in Touch

The Partnership Tree   paul@thepartnersplatform.com

 
 

© 2026 The Partnership Tree | All Rights Reserved.